JDRF T1D FUND LLC reported 2 transactions at PANDION THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/21/2020ACC: 0000899243-20-019886
10% Owner
Since Jul 2020
-1.65M
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
426.33K acquired · 2.08M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+204.31K
Price / share
—
Trade value
—
% of position
New position
7/21/2020
0.00→204.31K
Common Stock
Direct
Shares
+222.02K
Price / share
—
Trade value
—
% of position
108.7%
7/21/2020
204.31K→426.33K
Total
Net shares
+426.33K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/21/2020 | C · Conversion | +204.31K | — | — | New position | 0.00 | 204.31K |
| Common Stock Direct | 7/21/2020 | C · Conversion | +222.02K | — | — | 108.7% | 204.31K | 426.33K |
| Total | +426.33K | $0.00 | ||||||
Derivative Transactions2
Series A Prime Preferred Stock
Direct
Converts to
Common Stock
204.31K shares
Shares
−948.23K
Strike price
Held after
0.00
Exercisable
—
7/21/2020
Series B Preferred Stock
Direct
Converts to
Common Stock
222.02K shares
Shares
−1.13M
Strike price
Held after
0.00
Exercisable
—
7/21/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Prime Preferred Stock Direct | Common Stock204.31K shares | 7/21/2020 | C · Conversion | −948.23K | — | 0.00 | |
| Series B Preferred Stock Direct | Common Stock222.02K shares | 7/21/2020 | C · Conversion | −1.13M | — | 0.00 |